Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India:…
GlobalData reports the rise in HER2+ breast cancer cases, stressing the importance of cost-effective biosimilars as Zydus and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
breast cancer
AstraZeneca’s breast cancer drug combination fails in late-stage trial
The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients
Puma Biotechnology announces presentation of findings from a phase II study of alisertib in…
Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib Puma Biotechnology, announced the…
Zum Heilen announces patent for cardamom-based nutraceutical Recovereez
Launches Recovereez at the World Spice Congress
Scientists investigate if prostate drug could also treat breast cancer that’s spread to the bone
When breast cancer cells spread to other parts of the body it is called secondary or metastatic breast cancer and although…
Glenmark reduces cost of Trastuzumab treatment in India
A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country
Alembic Pharma gets USFDA nod for Docetaxel Injection USP
Docetaxcel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric…
NATCO announces ANDA filing for generic olaparib tablets in US
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer
Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe
Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Israeli scientists find promising target for breast cancer and other cancer therapeutics
Our perception of the specific multistep molecular mechanistic process which regulates cancer initiation and progression found in…